Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22O2 |
Molecular Weight | 270.3661 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](O)[C@@]1(C)C=CC3=C4CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=MEHHPFQKXOUFFV-OWSLCNJRSA-N
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h8-10,15-17,20H,2-7H2,1H3/t15-,16+,17+,18+/m1/s1
DescriptionCurator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1d618f-7e27-4307-9330-0e1a2255ee95
http://www.wikidoc.org/index.php/Trenbolone
Curator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1d618f-7e27-4307-9330-0e1a2255ee95
http://www.wikidoc.org/index.php/Trenbolone
Trenbolone is an anabolic steroid. It is used on livestock to increase muscle growth and appetite. Trenbolone compounds have a binding affinity for the androgen receptor three times as high as that of testosterone. Once metabolized, the drugs have the effect of increasing nitrogen uptake by muscles, leading to an increase in the rate of protein synthesis. It also has the secondary effects of stimulating appetite, reducing the amount of fat being deposited in the body, and decreasing the rate of catabolism. Short-term side effects include insomnia, high blood pressure, increased aggression, night sweats, and libido.
CNS Activity
Sources: http://www.ncbi.nlm.nih.gov/pubmed/25461682
Curator's Comment: Known to be CNS penetrant in rat. Human data not available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1871 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11252818 |
0.15 nM [Kd] | ||
Target ID: CHEMBL208 Sources: http://www.ncbi.nlm.nih.gov/pubmed/11252818 |
|||
Target ID: CHEMBL2034 Sources: http://www.ncbi.nlm.nih.gov/pubmed/3486322 |
53.0 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Finaplix®-H Approved UseIncreases rate of weight gain and improves feed efficiency. Launch Date1987 |
PubMed
Title | Date | PubMed |
---|---|---|
Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. | 2001 May |
|
In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant. | 2002 Dec |
|
Fluctuating asymmetry and growth as biomarkers for exposure to androgen disrupting chemicals in Japanese quail. | 2005 Aug |
|
Evaluation of the rodent Hershberger bioassay using three reference (anti)androgens. | 2005 Jun |
|
Doping control analysis in human urine by liquid chromatography-electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: determination of corticosteroids and quantification of ephedrines, salbutamol and morphine. | 2006 Jul 28 |
|
Determination of anabolic steroids in muscle tissue by liquid chromatography-tandem mass spectrometry. | 2007 Oct 17 |
|
Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry. | 2008 |
|
Confirmatory analysis of Trenbolone using accurate mass measurement with LC/TOF-MS. | 2008 Jun 16 |
|
The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. | 2008 Nov 28 |
|
Confirmatory method for the determination of nandrolone and trenbolone in urine samples using immunoaffinity cleanup and liquid chromatography-tandem mass spectrometry. | 2009 Nov 13 |
|
Analysis of anabolic steroids in hair: time courses in guinea pigs. | 2009 Sep |
Patents
Sample Use Guides
One implant containing 200 mg trenbolone acetate is administered to each animal. The implant is placed under the skin on the posterior aspect of the ear by means of a special implanter.
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12441365
Trenbolone was a high-affinity ligand for the androgen receptor (AR), with an IC(50) of about 4 nM in rat ventral prostate cytosol and about 33 nM in cells transfected with the human AR.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Trenbolone
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
||
|
CFR |
21 CFR 556.739
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
||
|
NCI_THESAURUS |
C2360
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
||
|
DEA NO. |
4000
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2916
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
SUB11232MIG
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
25015
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
1484278
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | RxNorm | ||
|
P53R4420TR
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
P53R4420TR
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
TRENBOLONE
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
100000077481
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
m11015
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID0034192
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
DB11551
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
10161-33-8
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL1698011
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY | |||
|
C95072
Created by
admin on Fri Dec 15 16:40:48 GMT 2023 , Edited by admin on Fri Dec 15 16:40:48 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE INACTIVE (PARENT)